Effects of omega-3 fatty acid supplementation on tumor-bearing rats
- PMID: 15501111
- DOI: 10.1016/j.jamcollsurg.2004.07.014
Effects of omega-3 fatty acid supplementation on tumor-bearing rats
Abstract
Background: Dietary fish oil (rich in omega-3 fatty acids: eicosapentaenoic acid and docosahexaenoic acid) suppresses synthesis and activity of proinflammatory cytokines that induce anorexia. We hypothesized that dietary fish oil reverses the feeding pattern of tumor anorexia, increasing food intake and retarding tumor growth.
Study design: Thirty-two Fischer rats were placed in Automated Eater Meter cages and randomly divided into four groups: tumor bearing (TB) rats eating normal chow diet (TB-Chow); TB rats eating chow diet supplemented with omega-3 fatty acids (TB-omega-3FA); Controls, non-tumor bearing (NTB) rats eating normal chow (NTB-Chow); and NTB rats with omega-3 fatty acid supplementation (NTB-omega-3FA). Doses of 10(6) methylcholanthrene (MCA) sarcoma cells were subcutaneously injected in TB rats. Daily food intake, meal size (MZ), meal number (MN), body weight, and tumor volume were measured, and rats were euthanized at onset of anorexia. Data were statistically analyzed using analyses of variance (ANOVA) and t-tests. Data are reported as mean +/- SE.
Results: Tumor appeared significantly earlier in TB-Chow than in TB-omega-3FA rats (7.5 +/- 0.3 days versus 11.6 +/- 0.8 days, p < 0.05). Daily food intake declined significantly in TB-Chow versus TB-omega-3FA rats 18 days after tumor inoculation and, at onset of anorexia, was 9.41 +/- 1.77 g/day versus 13.32 +/- 0.81 g/day, p < 0.05. Food intake decreased initially by decrease in meal number (at day 15) followed by a decrease in meal size (at day 18). At onset of anorexia, meal size and meal number were significantly decreased in TB-Chow versus TB-omega-3FA rats (0.75 +/- 0.067 g/meal versus 1.05 +/- 0.08 g/meal, p < 0.05) and (9.5 +/- 1.32 versus 12.79 +/- 0.93 meals/day, p < 0.05), respectively. Tumor volume was significantly smaller in TB-omega-3FA versus TB-Chow rats (7.6 +/- 0.6 cm(3) versus 16.5 +/- 1.0 cm(3), p < 0.05), as was tumor weight (7.5 +/- 2.2 g versus 18.1 +/- 1.6 g, p < 0.05).
Conclusions: In TB rats, omega-3FA improved food intake; restored normal eating pattern, delayed onset of anorexia, tumor appearance, and growth; and prevented body weight loss. Supplementation of omega-3 fatty acids has therapeutic potential in cancer anorexia.
Similar articles
-
Effects of omega-3 fatty acids on orexigenic and anorexigenic modulators at the onset of anorexia.Brain Res. 2005 Jun 7;1046(1-2):157-64. doi: 10.1016/j.brainres.2005.03.052. Brain Res. 2005. PMID: 15927553
-
Omega-3 fatty acids improve appetite in cancer anorexia, but tumor resecting restores it.Surgery. 2006 Feb;139(2):202-8. doi: 10.1016/j.surg.2005.08.001. Surgery. 2006. PMID: 16455329
-
Potential strategies for ameliorating early cancer anorexia.J Surg Res. 1999 Jan;81(1):69-76. doi: 10.1006/jsre.1998.5460. J Surg Res. 1999. PMID: 9889061
-
Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.Int J Toxicol. 2007;26 Suppl 1:3-106. doi: 10.1080/10915810601163939. Int J Toxicol. 2007. PMID: 17365137 Review.
-
Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.Herz. 2004 Nov;29(7):673-85. doi: 10.1007/s00059-004-2602-4. Herz. 2004. PMID: 15580322 Review.
Cited by
-
Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.Oncogene. 2019 Mar;38(12):2135-2150. doi: 10.1038/s41388-018-0569-5. Epub 2018 Nov 20. Oncogene. 2019. PMID: 30459358 Free PMC article.
-
Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.J Clin Invest. 2020 Sep 1;130(9):4921-4934. doi: 10.1172/JCI138392. J Clin Invest. 2020. PMID: 32544087 Free PMC article.
-
Hypothalamic integration of immune function and metabolism.Prog Brain Res. 2006;153:367-405. doi: 10.1016/S0079-6123(06)53022-5. Prog Brain Res. 2006. PMID: 16876587 Free PMC article. Review.
-
The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.Curr Pharm Des. 2012;18(31):4779-99. doi: 10.2174/138161212803216951. Curr Pharm Des. 2012. PMID: 22632859 Free PMC article. Review.
-
Marine phospholipids--a promising new dietary approach to tumor-associated weight loss.Support Care Cancer. 2010 Feb;18(2):159-70. doi: 10.1007/s00520-009-0640-4. Epub 2009 Apr 29. Support Care Cancer. 2010. PMID: 19404684 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical